Venous Leg Ulcer: Clinical Trials

4 trials for Venous Leg Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Venous Leg Ulcer: new trials by email Literature Review of Venous Leg Ulcer trials Research Report on Venous Leg Ulcer

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
XSTEM-VLU, Vehicle - Venous Leg Ulcer
Phase 1 / Phase 2CompletedXintela AB62022-10-262026-06-26
Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers
PRP, Conventional therapy - Venous Leg Ulcer
Phase 1CompletedJinnah Postgraduate Medical Centre482022-09-012023-08-03
Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds
SoftOx Biofilm Eradicator (Groups 1 to 7), Sterile isotonic saline (Groups 1 to 4) - Chronic Leg Ulcer, Venous Leg Ulcer
Phase 1CompletedSoftOx Solutions AS282021-10-192023-02-02
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Granexin - Venous Leg Ulcer
Phase 1CompletedXequel Bio, Inc.102015-09-012018-08-01

Narrower conditions

Varicose Ulcer (4)

Broader conditions

Cardiovascular Diseases (4)  ·  Leg Ulcer (4)  ·  Skin Diseases (4)  ·  Skin Ulcer (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Varicose Veins (4)  ·  Vascular Diseases (4)

Sponsors

Jinnah Postgraduate Medical Centre (1)  ·  SoftOx Solutions AS (1)  ·  Xequel Bio, Inc. (1)  ·  Xintela AB (1)

Countries

Denmark (1)  ·  Pakistan (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

David Peick Sonne, MD; PhD (1)  ·  Glenn Gundersen, PhD (1)  ·  Rabia Ghafoor (1)